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Skeletal muscle is the largest metabolic organ in the body, and its metabolic ﬂexibility is essential for maintaining systemic energy
homeostasis. Metabolic inﬂexibility in muscles is a dominant cause of various metabolic disorders, impeding muscle development.
In our previous study, we found lncRNA ZFP36L2-AS (for “ZFP36L2-antisense transcript”) is speciﬁcally enriched in skeletal muscle.
Here, we report that ZFP36L2-AS is upregulated during myogenic differentiation, and highly expressed in breast and leg muscle. In
vitro, ZFP36L2-AS inhibits myoblast proliferation but promotes myoblast differentiation. In vivo, ZFP36L2-AS facilitates intramuscular
fat deposition, as well as activates fast-twitch muscle phenotype and induces muscle atrophy. Mechanistically, ZFP36L2-AS interacts
with acetyl-CoA carboxylase alpha (ACACA) and pyruvate carboxylase (PC) to induce ACACA dephosphorylation and damaged PC
protein stability, thus modulating muscle metabolism. Meanwhile, ZFP36L2-AS can activate ACACA to reduce acetyl-CoA content,
which enhances the inhibition of PC activity. Our ﬁndings present a novel model about the regulation of lncRNA on muscle
metabolism.
Cell Death and Disease (2022)13:389 ; https://doi.org/10.1038/s41419-022-04772-2

INTRODUCTION
As the largest tissue that comprises about 40% of the total body
mass, skeletal muscle is a major player in regulating energy
homeostasis and obesity progression [1–3]. A key metabolic
feature of skeletal muscle is its plasticity, which is able to adjust
fuel oxidation to fuel availability, called ‘metabolic ﬂexibility’ [4, 5].
It’s well known that the metabolic regulation of skeletal muscle is
pivotal for health and development, and loss of this ﬂexibility is
tightly associated with metabolic disorders such as obesity and
muscle wasting [4, 6–8].
The maintenance of skeletal muscle mass is ﬁnely regulated by
protein synthesis and catabolism [9]. Muscle atrophy refers to a
decrease in muscle mass and ﬁber size and is characterized by
enhanced protein degradation [10]. Muscle atrophy leading to
muscle wasting seriously restricts animal development. Recently,
muscle wasting has attracted many researchers’ attention,
however, the molecular mechanisms that govern muscle atrophy
remain largely unknown.
Protein-encoding genes only account for a small portion (2%) of
the genome, and yet 70–90% of the genome is transcribed into
long noncoding RNAs (lncRNAs) at some point during development [11]. LncRNAs are a new class of regulatory RNAs, commonly
deﬁned as transcribed RNAs of more than 200 nucleotides with
low coding potential, are widely involved in gene expression
regulation at the transcription, translation and epigenetic levels
[12–16]. Although only a small number of functional lncRNAs have
been well characterized to date, they seem to control major

biological processes impacting skeletal muscle development and
muscle disorders [17–20].
White recessive rock (WRR) is a hypertrophic broiler chicken with
a fast growth rate, which exhibits a different growth performance
from Xinghua (XH) chicken (a lean Chinese native breed with a
slow growth rate) [21, 22]. In our previous RNA-seq study
(accession number GSE58755), we found lncRNA TCONS_00067025
(named ZFP36 ring ﬁnger protein like 2 [ZFP36L2]-antisense
transcript [ZFP36L2-AS]) differentially expressed between WRR (a
fast growth rate broiler chicken) and XH chicken (a slow growth
rate Chinese native breed) [22]. In the current study, functional
studies demonstrated that ZFP36L2-AS inhibits myoblast proliferation but promotes myogenic differentiation in vitro. In vivo,
ZFP36L2-AS represses fatty acid oxidation to facilitate intramuscular
fat deposition, as well as activates fast-twitch muscle phenotype
and induces muscle atrophy. Further mechanistic investigation
revealed that ZFP36L2-AS interacts with acetyl-CoA carboxylase
alpha (ACACA) and pyruvate carboxylase (PC) to induce ACACA
activation and inhibit PC activity. Altogether, our studies uncover a
functional lncRNA that modulates skeletal muscle development.
RESULTS
ZFP36L2-AS is a novel lncRNA associated with skeletal muscle
development
Our previous RNA-seq study found a novel lncRNA (ZFP36L2-AS)
was highly expressed in fast growth rate broilers (Fig. 1A, B) [22],
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Fig. 1 Identiﬁcation of lncRNA ZFP36L2-AS. A, B Relative ZFP36L2-AS expression in breast muscles of 7-week-old Xinghua (XH) chicken and
White recessive rock (WRR) detected by RNA-seq (A) and qPCR (B). (C) Results of ZFP36L2-AS 3’ RACE and 5’ RACE. D Relative ZFP36L2-AS
expression during CPM proliferation and differentiation. E Tissue expression proﬁles of ZFP36L2-AS. The horizontal axis and vertical axis
indicate different tissues and their relative expression values, respectively. F, G The distribution of ZFP36L2-AS in the cytoplasm and nuclei of
chicken primary myoblast (CPM) was determined by qPCR (F) and semi-qPCR (G). GAPDH and U6 serve as cytoplasmic and nuclear localization
controls, respectively. H Western blot analysis of the coding ability of ZFP36L2-AS. The potential ORFs of ZFP36L2-AS were cloned into the
pcDNA3.1-3xFlag-C vector. CPMs transfected with β-actin were used as a positive control (PC) and untransfected CPMs were used as a
negative control (NC). Results are presented as mean ± SEM. In panels (A, B), statistical signiﬁcance of differences between means was
assessed using independent sample t-test. (*P < 0.05; **P < 0.01).

implied that ZFP36L2-AS is probably associated with skeletal
muscle development. To obtain the full-length of ZFP36L2-AS, 5’
and 3’ ends of this lncRNA were determined by RACE system (Fig.
1C). The Basic Local Alignment Search Tool (BLAST) of the National
Center for Biotechnology Information (NCBI) showed that
ZFP36L2-AS was an antisense transcript of ZFP36L2 with 3,465 nt
long, located at chromosome 3 from 25,089,365 to 25,092,829,
and mainly conserved in Aves (Supplementary Fig. 1A and Table
1). ZFP36L2-AS was upregulated during myogenic differentiation,
and highly expressed in breast and leg muscle (Fig. 1D, E).
Compared with other muscle-resident cells, ZFP36L2-AS was highly
expressed in myoblasts (Supplementary Fig. 1B). Furthermore, cellfractionation assays demonstrated that ZFP36L2-AS was present

both in the cytoplasm and nucleus of chicken primary myoblast
(CPM) (Fig. 1F, G). In order to verify the coding potential of
ZFP36L2-AS, we further cloned 3xFLAG epitope tag in-frame with
the C terminus of thirteen potential ORFs of ZFP36L2-AS. Crucially,
western blot analysis indicated that ZFP36L2-AS was an lncRNA
without protein-encoding potential (Fig. 1H).
ZFP36L2-AS inhibits myoblast proliferation but promotes
myogenic differentiation
Given that ZFP36L2-AS was decreased in myoblast proliferation
and upregulated during myogenic differentiation (Fig. 1D), we
performed overexpression and inhibition experiments to assess its
effect in proliferation and differentiation of myoblast (Fig. 2A and
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Fig. 2 lncRNA ZFP36L2-AS inhibits myoblast proliferation but promotes myoblast differentiation. A Relative ZFP36L2-AS expression with
ZFP36L2-AS interference in vitro. B Proliferation of transfected CPMs was assessed by 5-ethynyl-2’-deoxyuridine (EdU) incorporation.
C Proliferation rate of myoblasts after interference of ZFP36L2-AS. D CCK-8 assays were performed in CPMs with ZFP36L2-AS interference. E Cell
cycle analysis of myoblasts after interference of ZFP36L2-AS. F Relative mRNA levels of several cell cycle genes with ZFP36L2-AS interference.
G–I MyHC immunostaining (G), myotube area (%) (H), and myoblast fusion index (I) of CPMs transduced with ZFP36L2-AS interference. Cells
were differentiated for 72 h after transfection. The nuclei were visualized with 4′,6-diamidino-2phenylindole (DAPI). J, K Relative mRNA (J) and
protein (K) expression levels of myoblast differentiation marker genes from si-ASO-ZFP36L2-AS transfected CPMs. The numbers shown below
the bands were folds of band intensities relative to control. Band intensities were quantiﬁed by ImageJ and normalized to β-Tubulin. Data are
expressed as a fold-change relative to the control. Results are shown as mean ± SEM. In panels (A, C–F, and H–J), statistical signiﬁcance of
differences between means was assessed using independent sample t-test. (*P < 0.05; **P < 0.01; N.S. no signiﬁcant difference).

Supplementary Fig. 2A). The 5-ethynyl-2′-deoxyuridine (EdU)
staining and cell counting kit-8 (CCK-8) assay demonstrated that
ZFP36L2-AS interference signiﬁcantly increased EdU incorporation
and promoted myoblast proliferation, whereas ZFP36L2-AS overexpression signiﬁcantly inhibited the proliferation of myoblast
(Fig. 2B–D and Supplementary Fig. 2B–D). Flow cytometric analysis
showed that ZFP36L2-AS inhibition signiﬁcantly reduced the
number of cells that progressed to G0/G1 and increased the
number of S phase cells (Fig. 2E). Conversely, ZFP36L2-AS
overexpression resulted in a larger number of G0/G1 and fewer
S phase cells (Supplementary Fig. 2E). Furthermore, inhibition of
ZFP36L2-AS increased the expression of cell cycle-promoting
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genes such as CCNB2 and CCND1, while reduced cell cycleinhibiting genes like CDKN1A and CDKN1B (Fig. 2F). And the
opposite result was observed with ZFP36L2-AS overexpression
(Supplementary Fig. 2F).
To further test whether ZFP36L2-AS functions in myogenic
differentiation, immunoﬂuorescence staining was performed after
overexpression and inhibition of ZFP36L2-AS. ZFP36L2-AS inhibition signiﬁcantly repressed myoblast differentiation and
decreased the total areas of myotubes, while myotube formation
was facilitated with ZFP36L2-AS overexpression (Fig. 2G–I and
Supplementary Fig. 2G–I). In addition, the expressions level of
myoblast differentiation marker genes, including MYOD, MYOG,
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Fig. 3 lncRNA ZFP36L2-AS represses cellular respiration and fatty acid oxidation in skeletal muscle. A, B Oxygen consumption rate (OCR)
(A), and basal respiration, maximal respiration, and ATP production (B) of myoblasts after interference of ZFP36L2-AS. (C, D) Extracellular
acidiﬁcation rate (ECAR) (C), and glycolysis and glycolytic capacity (D) of myoblasts with ZFP36L2-AS interference. E Relative cellular adenosine
triphosphate (ATP) content with ZFP36L2-AS interference in CPMs. F Relative ZFP36L2-AS expression in gastrocnemius after infected with
lentivirus-mediated ZFP36L2-AS knockdown (Lv-shZFP36L2-AS) or negative control (Lv-NC). G Relative mitochondrial DNA (mtDNA) content in
ZFP36L2-AS knockdown gastrocnemius. (H) Relative fatty acid β-oxidation rate in gastrocnemius with ZFP36L2-AS knockdown. I, J Relative
mRNA (I) and protein (J) expression levels of fatty acid oxidation or synthesis related-genes after infected with the indicated lentivirus. The
numbers shown below the bands were folds of band intensities relative to control. Band intensities were quantiﬁed by ImageJ and normalized
to β-Tubulin. Data are expressed as a fold-change relative to the control. K Relative free fatty acid (FFA) and triglyceride (TG) content in
gastrocnemius with ZFP36L2-AS knockdown. Results are presented as mean ± SEM. In panels (B, D–I, and K), statistical signiﬁcance of
differences between means was assessed using independent sample t-test. (*P < 0.05; **P < 0.01).

and MyHC were signiﬁcantly downregulated with ZFP36L2-AS
interference (Fig. 2J, K). Conversely, overexpression of ZFP36L2-AS
promoted their expression (Supplementary Fig. 2J, K).
ZFP36L2-AS decreases cellular respiration, fatty acid
oxidation, and TCA cycle metabolites in skeletal muscle
Cellular mitochondrial activities including oxygen consumption
rate (OCR), basal and maximal mitochondrial respiration, and
adenosine triphosphate (ATP) production were elevated with

ZFP36L2-AS interference, whereas ZFP36L2-AS overexpression
facilitated glycolysis (Fig. 3A–D and Supplementary Fig. 3A–D),
indicating that ZFP36L2-AS may be involved in cellular energy
metabolism. Meanwhile, inhibition of ZFP36L2-AS increased ATP
content in myoblast, while ATP content was decreased with
ZFP36L2-AS overexpression in myoblasts (Fig. 3E and Supplementary Fig. 3E). Given that ZFP36L2-AS regulates cellular metabolism,
we further detected the cellular ATP content in satellite cells after
inhibition and overexpression of ZFP36L2-AS to explore whether
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Fig. 4 Knockdown of lncRNA ZFP36L2-AS downregulates the TCA cycle. A Hierarchical clustering analysis (HCA) of metabolites in
gastrocnemius after infected with Lv-shZFP36L2-AS or Lv-NC. The colors indicate the relative levels in lncRNA ZFP36L2-AS knockdown or
control group. B Relative metabolite content of glycolysis and tricarboxylic acid (TCA) cycle in gastrocnemius with ZFP36L2-AS knockdown.
C Schematic diagram of metabolic pathways of glycolysis and TCA cycle affected by ZFP36L2-AS knockdown in the gastrocnemius.
Upregulated metabolites are shown in red, and the downregulated metabolites are shown in green. In panel (C), results are shown as mean ±
SEM, statistical signiﬁcance of differences between means was assessed using independent sample t-test. (*P < 0.05; **P < 0.01).

ZFP36L2-AS plays a metabolic regulatory role in satellite cells
similar to that in myoblasts. The results shown that ZFP36L2-AS did
not regulate cellular ATP content in satellite cells (Supplementary
Fig. 4A, B), suggesting the function of ZFP36L2-AS in muscle
metabolism mainly depends on its expression in myoblasts. To
investigate the potential roles of ZFP36L2-AS in vivo, the
gastrocnemius of 1day-old chick was injected with adenovirusmediated ZFP36L2-AS overexpression (Adv-ZFP36L2-AS) or
lentivirus-mediated ZFP36L2-AS knockdown (Lv-shZFP36L2-AS)
(Fig. 3F and Supplementary Fig. 3F). ZFP36L2-AS knockdown
increased mitochondrial DNA content, which was potentially
contribute to the acceleration of fatty acid oxidation (FAO) (Fig.
3G, H). In contrast, mitochondrial DNA content and fatty acid
β-oxidation were reduced after overexpression of ZFP36L2-AS
(Supplementary Fig. 3G, H). Besides, knockdown of ZFP36L2-AS
upregulated the expression of FAO-related gene like CPT1, but
downregulated key genes involved in fatty acid synthesis (such as
FASN, MCAT and OXSM) and reduced intramuscular free fatty acid
(FFA) and triglyceride (TG) content (Fig. 3I–K). Meanwhile, opposite
results were showed with ZFP36L2-AS overexpression (Supplementary Fig. 3I–K).
Excessive lipid storage is often accompanied by changes in
muscle metabolism [23–26]. To further study the regulation of
ZFP36L2-AS on muscle metabolism, a comparative metabolome
analysis was performed with ZFP36L2-AS knockdown in gastrocnemius. Hierarchical clustering analysis (HCA) based on
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metabolite levels showed that several tricarboxylic acid cycle
(TCA cycle) metabolites actually accumulate in ZFP36L2-AS knockdown gastrocnemius (Fig. 4A, B and Supplementary Table 2). On
the contrary, ZFP36L2-AS knockdown signiﬁcantly reduced glycolytic metabolites such as Fructose 1,6-bisphosphate and Dihydroxyacetone phosphate (Fig. 4A, B and Supplementary Table 2).
Altogether, our results indicated that ZFP36L2-AS impairs mitochondrial respiration and FAO, leading to the accumulation of
lipid metabolites, which elevates glycolysis as compensatory
responses (Fig. 4C).
ZFP36L2-AS activates a fast-twitch gene expression proﬁle
concurrent with muscle atrophy
Skeletal muscle is comprised of heterogeneous myoﬁbers that
differ in their physiological and metabolic parameters [27].
Compared with fast-twitch (type II; glycolytic) myoﬁbers, slowtwitch (type I; oxidative) myoﬁbers have more myoglobin, more
mitochondria, and higher activity of oxidative metabolic enzymes
[28, 29]. In response to environmental demands, skeletal muscle
can remodel by activating signaling pathways to reprogram gene
expression to sustain muscle performance [27]. Given that
knockdown of ZFP36L2-AS reduced the accumulation of glycolytic
metabolites and upregulated oxidative metabolism in gastrocnemius (Fig. 4B, C), ZFP36L2-AS may function in the transformation of
myoﬁber type by modulating muscle metabolism. As expected,
glycogen content was increased and expression of glycogenolytic
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Fig. 5 lncRNA ZFP36L2-AS activates a fast-twitch gene expression proﬁle concurrent with muscle atrophy. A Relative glycogen content in
gastrocnemius with ZFP36L2-AS knockdown. B Relative mRNA expression levels of glycogenolytic and glycolytic genes in gastrocnemius after
infected with the indicated lentivirus. (C) Relative enzymes activity of lactic dehydrogenase (LDH) and succinate dehydrogenase (SDH) in
gastrocnemius infected with ZFP36L2-AS knockdown. D, E Immunohistochemistry analysis of MYH1/MYH7 (D) and MYH1/MYH7 protein
content (E) of gastrocnemius after ZFP36L2-AS knockdown. (F) Relative mRNA expression levels of several fast-/slow-twitch myoﬁber genes
with ZFP36L2-AS knockdown. G Relative gastrocnemius muscle weight after infected with the indicated lentivirus. H, I H&E staining (H) and
frequency distribution of ﬁber cross-section area (CSA) (I) of transverse sections of gastrocnemius with ZFP36L2-AS knockdown. J Relative
mRNA expression of the atrophy and autophagy-related genes in gastrocnemius after infected with the indicated lentivirus. K The protein
expression levels of mTOR signaling after ZFP36L2-AS knockdown. The numbers shown below the bands were folds of band intensities relative
to control. Band intensities were quantiﬁed by ImageJ and normalized to β-Tubulin. Data are expressed as a fold-change relative to the
control. Results are presented as mean ± SEM. In panels (A–C, E–G, and J), statistical signiﬁcance of differences between means was assessed
using independent sample t-test. (*P < 0.05; **P < 0.01).

and glycolytic genes was downregulated with ZFP36L2-AS knockdown (Fig. 5A, B). Inversely, overexpression of ZFP36L2-AS reduced
the accumulation of glycogen, as well as promoted expression of
glycogenolytic and glycolytic genes (Supplementary Fig. 5A, B).
ZFP36L2-AS knockdown suppressed the activity of lactic dehydrogenase (LDH) and enhanced the activity of succinate
dehydrogenase (SDH), whereas ZFP36L2-AS overexpression elevated glycolytic capacity and decrease oxidative capacity of
skeletal muscle (Fig. 5C and Supplementary Fig. 5C). More
importantly, immunohistochemical results showed that ZFP36L2AS knockdown suppressed MYH1A/fast-twitch protein level and
promoted the expression level of MYH7B/slow-twitch protein (Fig.
5D, E). The expressions of multiple fast-twitch myoﬁber genes
such as SOX6, TNNC2 and TNNT3 were signiﬁcantly promoted,
while slow-twitch myoﬁber genes like TNNC1, TNNI1 and TNNT1

were inhibited with ZFP36L2-AS knockdown (Fig. 5F). On the
contrary, ZFP36L2-AS overexpression upregulated fast-twitch
protein level and expression of fast-twitch myoﬁber genes, drove
the transformation of slow-twitch to fast-twitch myoﬁbers
(Supplementary Fig. 5D–F).
Muscle remodeling can also affect muscle mass; this is
regulated by anabolic and catabolic signaling pathways, which
induce muscle hypertrophy and muscle atrophy, respectively [30].
Here, ZFP36L2-AS knockdown increased muscle mass and elevated
the proportion of large myoﬁber (> 200 μm2) (Fig. 5G–I). Conversely, gastrocnemius mass was reduced and proportion of small
myoﬁber (< 200 μm2) was increased with overexpression of
ZFP36L2-AS (Supplementary Fig. 5G–I), suggesting ZFP36L2-AS is
involved in muscle atrophy. Mammalian target of rapamycin
(mTOR) is a master growth regulator that senses and integrates
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Fig. 6 lncRNA ZFP36L2-AS interacts with ACACA and PC to induce ACACA dephosphorylation and inhibit PC protein stabilization.
A, B lncRNA ZFP36L2-AS interacts with ACACA and PC protein were determined by biotin-labeled RNA pulldown (A) and RIP (B). C The
interaction of full-length and truncated ZFP36L2-AS with ACACA and PC protein was determined by RNA pulldown. D–G The protein
expression levels of ACACA and phosphorylated ACACA (D, F), and relative ACACA activity (E and G) after ZFP36L2-AS overexpression or
knockdown in vitro and in vivo. H–K The protein expression level of PC (H, J), and relative PC activity (I, K) after ZFP36L2-AS overexpression or
knockdown in vitro and in vivo. (L) The protein expression level of PC in ZFP36L2-AS overexpressed myoblast was analyzed after incubated
with the protein synthesis inhibitor cycloheximide (CHX; 25 µg/ml). (M) The protein expression level of PC in ZFP36L2-AS knockdowned
myoblast was analyzed after incubated with the proteasome inhibitor (MG-132; 5 µmol/L) for 12 h. N, O Relative acetyl-CoA content (N), and
relative PC activity (O) with ACACA interference in vitro. P Relative acetyl-CoA content with ZFP36L2-AS overexpression or knockdown in vivo.
Q, R Relative acetyl-CoA content (Q), and relative PC activity (R) induced by the listed nucleic acids. In panels (D, F, H, J, L, and M), the numbers
shown below the bands were folds of band intensities relative to control. Band intensities were quantiﬁed by ImageJ and normalized to
β-Tubulin. Data are expressed as a fold-change relative to the control. Results are presented as mean ± SEM. In panels (E, G, I, K and N–P),
statistical signiﬁcance of differences between means was assessed using independent sample t-test. In panels (Q, R), ANOVA followed by
Dunnett’s test was used. (*P < 0.05; **P < 0.01; N.S., no signiﬁcant difference).
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Fig. 7 ACACA and PC are required for the function of lncRNA ZFP36L2-AS. A, B) Relative fatty acid β-oxidation rate (A), and relative mRNA
levels of fatty acid oxidation or synthesis related-genes (B) after co-transfection with the listed nucleic acids in CPMs. C–J OCR (C), basal
respiration, maximal respiration and ATP production (D), ECAR (E), glycolysis and glycolytic capacity (F), relative mRNA expression levels of
glycogenolytic and glycolytic genes (G), relative enzymes activity of LDH and SDH (H), relative mRNA expression levels of several fast-/slowtwitch myoﬁber genes (I), and relative mRNA expression of the atrophy and autophagy-related genes (J) induced by the listed nucleic acids in
CPMs. Results are shown as mean ± SEM. In all panels, statistical signiﬁcance of differences between means was assessed using ANOVA
followed by Dunnett’s test. (*P < 0.05; **P < 0.01; N.S. no signiﬁcant difference).

diverse nutritional and environmental cues, can resist muscle
atrophy by inhibiting proteasomal degradation and autophagy
[30–32]. To further explore the regulatory mechanism of ZFP36L2AS on muscle atrophy, we assessed the mTOR signaling after
ZFP36L2-AS overexpression and knockdown. ZFP36L2-AS knockdown facilitated Ser2488 phosphorylation of mTOR, thus inactivating ubiquitin-proteasome system (UPS) and autophagy-lysosomal
system, while the mTOR signaling was inhibited with ZFP36L2-AS
overexpression (Fig. 5J, K and Supplementary Fig. 5J, K), indicating
that ZFP36L2-AS induces muscle atrophy by inhibiting the mTOR
signaling.
ZFP36L2-AS interacts with ACACA and PC
Molecular decoy is one of the main molecular mechanisms for
lncRNA to function. It refers to that lncRNA directly binds to RNA
or protein molecules, thereby activating or blocking the role and
signal pathway of these molecule [33]. To elucidate the
mechanism by which ZFP36L2-AS regulates skeletal muscle

development, we attempted to identify its endogenous binding
proteins by performing RNA pull-down coupled to mass spectrometry. Compared with the ZFP36L2-AS antisense group, a total of
141 proteins (protein score ≥ 19) were identiﬁed speciﬁcally bind
to ZFP36L2-AS sense transcript (Supplementary Table 3). Gene
ontology (GO) and Kyoto Encyclopedia of Genes and Genomes
(KEGG) enrichment analysis found that these RNA binding
proteins (RBPs) were mainly enriched in biological processes such
as cellular process, metabolic process, cellular component
organization or biogenesis, and biological regulation, as well as
participated in biological processes including metabolic pathways,
carbon metabolism, TCA cycle, pyruvate metabolism, glycolysis/
gluconeogenesis and so on (Supplementary Fig. 6A, B). Acetyl-CoA
carboxylase alpha (ACACA) and pyruvate carboxylase (PC) are
members of biotin-dependent carboxylase, which are known to be
widely involved in metabolic regulation [34–37], were found
speciﬁcally bind to ZFP36L2-AS (Supplementary Table 3). To
corroborate this result, we performed western blot analysis of
Cell Death and Disease (2022)13:389
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RNA pull-down samples, which validated the interaction of
ZFP36L2-AS with ACACA and PC protein (Fig. 6A). Moreover, the
speciﬁcity of these interactions was also veriﬁed with RNA
immunoprecipitation (RIP) (Fig. 6B).
To further map the ZFP36L2-AS functional motifs corresponding
to ACACA and PC binding, we conducted an in vitro RNA pulldown assay using a series of truncated ZFP36L2-AS fragments (Fig.
6C). This analysis revealed that nucleotides 816-1785 of ZFP36L2AS are sufﬁcient to interact with both ACACA and PC protein, while
other ZFP36L2-AS truncated fragments could not (Fig. 6C). As the
ZFP36L2-AS 816-1785 region is necessary for ZFP36L2-AS’s binding
to ACACA and PC protein, we overexpressed the truncated
fragment (816-1785 nt) and analyzed its impact on skeletal muscle
development. Similar results to ZFP36L2-AS full-length overexpression were found (Supplementary Fig. 7A–F), implying that the
interaction of ZFP36L2-AS with ACACA and PC protein may be a
requisite for ZFP36L2-AS to function.
The function of ZFP36L2-AS partially depends on its regulation
of ACACA and PC activity
With the observation that ZFP36L2-AS directly interacts with
ACACA and PC, we further analyzed the effect of ZFP36L2-AS on
ACACA and PC. Both in vitro and in vivo, the mRNA level of
ACACA and PC were not changed with ZFP36L2-AS overexpression and knockdown (Supplementary Fig. 8A–D). Overexpression of ZFP36L2-AS signiﬁcantly inhibited the phosphorylation
level of ACACA protein and increased ACACA activity, whereas
ZFP36L2-AS knockdown promoted ACACA phosphorylation and
inactivated ACACA (Fig. 6D–G and Supplementary Fig. 7G, H),
indicating that ZFP36L2-AS modulates the activity of ACACA by
regulating ACACA phosphorylation. Next, we investigated the
regulation of ZFP36L2-AS on the protein level and activity of PC.
ZFP36L2-AS overexpression downregulated PC protein level and
activity, while the protein level and activity of PC was increased
with ZFP36L2-AS knockdown (Fig. 6H–K and Supplementary Fig.
7I, J). Cycloheximide (CHX) is a bacterial toxin that can inhibit
protein biosynthesis. Treated with CHX decreased the expression of PC protein (Fig. 6L). However, ZFP36L2-AS knockdown
relieved the decline of PC protein expression induced by CHX
(Fig. 6L), suggesting that ZFP36L2-AS might promote the PC
protein degradation. To further clarify the possible mechanism,
the proteasome inhibitor MG-132 was used. MG-132 upregulated the protein levels of PC (Fig. 6M), suggesting that the
inhibition of ubiquitin-proteasome pathway might ameliorate
the degradation of PC. More importantly, MG-132 rescued the
reduction of PC protein levels in ZFP36L2-AS-overexpressing
myoblast (Fig. 6M). Overall, given that ZFP36L2-AS could
modulate the ubiquitination level of total protein (Fig. 5K and
Supplementary Fig. 5K), we infer ZFP36L2-AS induces the
ubiquitination of PC to facilitate PC degradation, thereby
inhibiting PC activity.
Acetyl-CoA is an allosteric activator of PC [38], has been found
that can be catalyzed by ACACA to produce malonyl-CoA for fatty
acid synthesis [39, 40], hinting that ACACA may affect the activity
of PC by regulating acetyl-CoA. To verify this conjecture, ACACA
was knockdown by speciﬁc siRNA (Supplementary Fig. 9A, B). As
expected, ACACA knockdown increased acetyl-CoA content and
enhanced the activity of PC (Fig. 6N, O). Similarly, ZFP36L2-AS
knockdown augmented acetyl-CoA content, whereas the content
of acetyl-CoA was reduced with overexpression of ZFP36L2-AS (Fig.
6P and Supplementary Fig. 7K). To further explore whether
ZFP36L2-AS can reinforce the regulation of PC activity via ACACA,
ZFP36L2-AS overexpression construct was co-transfected with
ACACA speciﬁc siRNA. Partly, knockdown of ACACA abolished the
downregulation of acetyl-CoA content and PC activity by ZFP36L2AS overexpression (Fig. 6Q, R), demonstrated that ZFP36L2-AS can
further enhance the inhibition of PC activity by activating ACACA.
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Tissue expression proﬁles showed ACACA and PC highly
expressed in breast and leg muscle (Supplementary Fig. 10A, D),
implying that they may play an important role in skeletal muscle
development. We further analyzed the expression of ACACA and PC
during myoblast proliferation and differentiation. ACACA was
slightly upregulated during myogenic differentiation, whereas the
expression of PC was visibly decreased (Supplementary Fig. 10B, E).
Moreover, subcellular location annotation showed that ACACA
protein exists in nucleus and cytosol, while PC is localized in
mitochondria (Supplementary Fig. 10C, F). To explore the potential
biological functions of ACACA and PC in myogenesis, we performed
a series of myoblast proliferation and differentiation assays. ACACA
knockdown had similar results with PC overexpression, which
promoted myoblast proliferation and inhibited myoblast differentiation (Supplementary Figs. 9C–L and 11A–L). In contrast, PC
interference suppressed myoblast proliferation but facilitated
myogenic differentiation (Supplementary Fig. 11M-X). Meanwhile,
overexpression of PC promoted cellular mitochondrial respiration,
whereas glycolytic capacity was increased with PC knockdown
(Supplementary Fig. 12A-H).
Considering the expression and functional relationship between
ZFP36L2-AS and ACACA and PC, we further determined the role of
ACACA and PC on ZFP36L2-AS-mediated skeletal muscle development. Knockdown of ACACA improved fatty acid β-oxidation rate and
upregulated the expression of CPT1, but downregulated key genes
involved in fatty acid synthesis, which counteracts the inhibitory
effect of ZFP36L2-AS on FAO (Fig. 7A, B). In addition, overexpression
of PC rescued the suppression of cellular mitochondrial respiration
induced by ZFP36L2-AS overexpression (Fig. 7C–F), as well as
attenuates the activation of fast-twitch phenotype and muscle
atrophy (Fig. 7G–J). Altogether, these results indicated that ACACA
and PC are indispensable to the function of ZFP36L2-AS.
DISCUSSION
Myogenesis is a highly ordered process including myoblast
proliferation and differentiation, myotube formation and maturity,
and is controlled by a series of myogenic regulatory factors
[30, 41–43]. After birth, the number of myoﬁbers in animals is
basically ﬁxed, and their skeletal muscle development is mainly
regulated by the composition and size of myoﬁbers. Recently, it is
becoming increasingly clear that a complex network of epigenetic
regulators and lncRNAs plays an essential role in skeletal muscle
development [17–20, 44]. In our previous RNA-seq data, we
identiﬁed lncRNA ZFP36L2-AS was highly expressed in fast growth
rate broilers. Here, we found ZFP36L2-AS was upregulated during
myogenic differentiation and highly expressed in breast and leg
muscle, indicating its potential role in muscle development. Gainand loss-of-function analysis revealed that ZFP36L2-AS inhibited
myoblast proliferation but promoted myoblast differentiation
in vitro. In vivo, ZFP36L2-AS activated fast-twitch muscle phenotype and induced muscle atrophy.
Skeletal muscle is a structurally and metabolically plastic tissue that
maintains systemic energy homeostasis in response to various
metabolic stresses [26]. Metabolic inﬂexibility in muscles is a
dominant cause of various metabolic disorders [5]. Notably, recent
evidences have revealed that the maintenance of skeletal muscle
mass is closely related to muscle metabolism [8]. In this study, we
found that ZFP36L2-AS repressed cellular mitochondrial respiration
and fatty acid oxidation in skeletal muscle, resulting in excessive
deposition of intramuscular fat. In the meantime, ZFP36L2-AS
elevated glycolytic capacity and decrease oxidative capacity of
skeletal muscle, which inactivated mTOR signaling, leading to the
activation of UPS and autophagy-lysosomal system and induced
muscle atrophy. Given that ZFP36L2-AS facilitated intramuscular fat
deposition and induced muscle atrophy, ZFP36L2-AS could be a
novel therapeutic target for obesity and sarcopenia.
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Post-transcriptional regulation is an important form for lncRNA
to regulate gene expression and function. Notably, increasing
studies revealed that lncRNAs can be widely involved in a variety
of biological processes through interacting with RBPs [44–47].
ACACA is a key enzyme in the process of fatty acid biosynthesis
and oxidation, whose Ser79 site phosphorylation would inhibit the
enzymatic activity of ACACA to promote FAO [48, 49]. In this study,
we found ZFP36L2-AS can interact with ACACA through its 8161785 region, thus inducing ACACA dephosphorylation and
facilitating intramuscular fat deposition. In addition, PC (an
enzyme that converts pyruvate to oxaloacetate), who has been
reported to function as a RBP [45], was also discovered to bind
with ZFP36L2-AS. ZFP36L2-AS damaged PC protein stability and
inhibited PC activity, which may be attributed to the induction of
ubiquitination by ZFP36L2-AS. Interestingly, we found ACACA can
reduce the activity of PC by consuming acetyl-CoA, demonstrating
that the inhibitory effect of ZFP36L2 on PC activity is partially
ACACA-dependent.
Skeletal muscle is mainly composed of myoﬁbers, which
develop from myoblasts through a highly ordered biological
process. In addition to myoblasts, skeletal muscle includes
many muscle-resident cells such as blood cells, ﬁbroblasts,
preadipocytes, and satellite cells. Compared to other muscleresident cells, we found that ZFP36L2-AS expression is more
pronounced in myoblasts, blood cells and satellite cells. Since
blood cells are mainly involved in oxygen transport and
immune function of the body and ZFP36L2-AS regulates
skeletal muscle development by mediating muscle metabolism, the function of ZFP36L2-AS in blood cells was not
investigated in depth. On the other hand, inhibition and
overexpression of ZFP36L2-AS did not change cellular ATP
content in satellite cells, suggesting the expression of ZFP36L2AS in satellite cells is not related to its role in muscle
metabolism. Overall, the function of ZFP36L2-AS in muscle
metabolism mainly depends on its expression in myoblasts,
which contributes to its regulation of myogenesis and skeletal
muscle development.
In summary, we identiﬁed lncRNA ZFP36L2-AS can interact with
ACACA and PC to facilitate intramuscular fat deposition, as well as
activate fast-twitch muscle phenotype and induce muscle atrophy
(Supplementary Fig. 13). Our ﬁndings present a novel model
about the regulation of lncRNA on muscle metabolism, and will
contribute to the development of further research.
MATERIALS AND METHODS
Cell culture and transfection
Chicken primary myoblasts (CPMs) were isolated from the leg muscle of
11-day old chicken embryos and cultured as previously described [50]. To
induce myogenic differentiation, growth medium was removed and
replaced with differentiation medium (RPMI-1640 medium [Gibco, MD,
USA] containing 2% horse serum after myoblasts achieving 90% cell
conﬂuence.
Fresh blood was collected from 14-day old chicken. After centrifugation
at 1,500 × g, plasma was removed and blood cells were collected.
Chicken primary ﬁbroblasts were isolated from the leg muscle of 10-day
old chicken embryos. Fibroblasts were trypsinized and then collected by
centrifugation as previously described [51]. Fibroblasts were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Gibco, USA) supplemented
with 10% (v/v) fetal bovine serum (FBS, Hyclone, USA) and 0.2% penicillin/
streptomycin (Invitrogen, USA).
Chicken preadipocytes were isolated from 14-day old chicken as
previously described [52], and cultured with DMEM/Ham’s nutrient mixture
F-12 (DMEM/F12) basic medium with 10% (v/v) FBS (Hyclone, USA) and
0.2% penicillin/streptomycin (Invitrogen, USA).
Chicken satellite cells were isolated from leg muscle of 15-day old
chicken embryos and cultured as previously described [53].
All cells were cultured at 37 °C in a 5% CO2 humidiﬁed atmosphere. And
all transient transfections were performed using Lipofectamine 3000
Reagent (Invitrogen, USA) according to the manufacturer’s instructions.

RNA extraction, cDNA synthesis and quantitative real-time
PCR (qRT-PCR)
Total RNA was extracted using Trizol reagent (TaKaRa, Otsu, Japan)
following the manufacturer’s protocol. Nuclear and cytoplasmic RNA
fractionation was performed by using the PARIS Kit (Ambion, Life
Technologies, USA) as recommended by the supplier. cDNA synthesis for
mRNA was carried out using the PrimeScript RT Reagent Kit with gDNA
Eraser (Perfect Real Time) (TaKaRa, Otsu, Japan). Real-time qPCR assay was
performed as described before [54]. And primers used for RT-PCR and qRTPCR are listed in Supplementary Table 4.

5ʹ and 3ʹ rapid-ampliﬁcation of cDNA ends (RACE)
5′ and 3′ RACE of ZFP36L2-AS was performed using SMARTer RACE cDNA
Ampliﬁcation Kit (Clontech, Osaka, Japan) according to the manufacturer’s
instructions. The gene-special primers used for RACE were presented in
Supplementary Table 4.

Plasmids construction and RNA oligonucleotides
For Flag fusion protein construction, thirteen ORFs of ZFP36L2-AS were
ampliﬁed and subcloned into HindIII and XhoI restriction sites in the
pcDNA3.1-3xFlag-C vector.
For overexpression vectors construction, the full-length sequence and
816-1785 nt of ZFP36L2-AS and PC coding sequence (NCBI Reference
Sequence: NM_204346.1) were ampliﬁed and cloned into the pcDNA-3.1
vector (Promega, Madison, WI, USA) by using the NheI and HindIII
restriction sites.
For viral vectors constructed, the full-length sequence of ZFP36L2-AS was
ampliﬁed, and then cloned into the adenoviral vector (pDC316-mCMVZsGreen; Addgene, Cambridge, MA, USA) between NheI and HindIII sites.
Short hairpin RNA (shRNA) against ZFP36L2-AS was designed by Shanghai
Hanbio Biotechnology Co., Ltd, and then subcloned into the pLVX-shRNA2Puro vector (Addgene, Cambridge, MA, USA) by using the BamHI and EcoRI
restriction sites.
The small interfering RNAs (siRNA) and antisense oligonucleotide (ASO)
that were used for the speciﬁc knockdown of ZFP36L2-AS were designed
and synthesized by Guangzhou RiboBio (Guangzhou, China). The siRNA
against ACACA (NCBI Reference Sequence: NM_205505.1) and PC were also
designed and synthesized.
The primers and oligonucleotide sequences used in this study are shown
in Supplementary Tables 4 and 5.

Flow cytometry, 5-Ethynyl-2’-deoxyuridine (EdU) and cell
counting kit-8 (CCK-8) assays
The experiments were performed as previously described [54]. In brief, the
Cell Cycle Analysis Kit (Thermo Fisher Scientiﬁc, USA), C10310 EdU Apollo
In Vitro Imaging Kit (RiboBio, China) and TransDetect Cell Counting Kit
(TransGen, Beijing, China) were used for ﬂow cytometry, EdU, and CCK-8
assay, as the manufacturer’s protocol.

Immunoblotting and immunoﬂuorescence (IF)
Western blots were performed as previously described [50]. The primary
antibodies used were anti-FLAG (AF519, 1:1,000, Beyotime), anti-ACACA
(PA5-17564, 1:1000, Thermo Fisher Scientiﬁc), anti-p-ACACA Ser80
(orb315750, 1:500, Biorbyt), anti-PC (GTX132002, 1:500, GeneTex), antiMYOD (ABP53067, 1:500, Abbkine), anti-MyHC (B103, 0.5 μg/ml, DHSB),
anti-CPT1 (bs-23779R, 1:500, Bioss), anti-FASN (10624-2-AP, 1:200, Proteintech), anti-p-mTOR Ser2488 (#5536, 1:1000, CST), anti-mTOR (bs-1992R,
1:500; Bioss), Ubiquitin (#39361:1000, CST) anti-ULK1 (bs-3602R, 1:500;
Bioss), anti-LC3B (NB100-2220, 2.0 ug/ml, Novus), anti-P62 (18420-1-AP,
1:1000, Proteintech) and anti-β-Tubulin (A01030, 1:10000, Abbkine).
ProteinFind Goat Anti-Mouse IgG(H + L), HRP Conjugate (HS201-01,
1:1,000, TransGen) and ProteinFind Goat Anti-Rabbit IgG(H + L), HRP
Conjugate (HS101-01, 1:500, TransGen) were used as a secondary antibody.
Immunoﬂuorescence was performed using anti-MyHC (B103, 2.5 μg/ml,
DHSB), as previously described [50]. A ﬂuorescence microscope ((DMi8;
Leica, German) was used to capture three randomly selected ﬁelds to
visualize the area labeled with anti-MyHC.

Mitochondrial respiration assay
The oxygen consumption rate (OCR) and extracellular acidiﬁcation rate
(ECAR) of transfected myoblasts were measured using Seahorse XF Cell
Mito Stress Test Kit and Seahorse XF Glycolysis Stress Test Kit (Agilent
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technologies, CA, USA) by a Seahorse XF96 Extracellular Flux Analyzer
(Agilent technologies, CA, USA) following the manufacturer’s protocol,
respectively.

Adenovirus/Lentivirus production and transduction
To generate adenovirus, the recombinant adentiviral expression plasmid
was co-transfected with pHBAd-BHGlox ΔE1,3Cre plasmid using Lipofectamine 3000 reagent. After ampliﬁcation, acquired adenovirus were puriﬁed
with a ViraBind™ Adenovirus Puriﬁcation Kit (Cell Biolabs, USA). Lentivirus
production was performed as previously described [54]. Viral titers were
evaluated by a gradient dilution.
1-day-old female chicks were randomly divided into two groups (AdvZFP36L2-AS and Adv-NC, or Lv-shZFP36L2-AS and Lv-shNC; n = 30),
respectively. Chicks received two intramuscular doses of adenovirus (108
titers)/lentivirus (106 titers) in two different sites of the gastrocnemius.
Thirteen days after the initial injection, chick gastrocnemius samples were
collected from the above two groups.

Mitochondrial DNA (mtDNA) content and fatty acid oxidation
(FAO) rate assay
Total DNA was extracted using the Tissue DNA Kit (D3396, Omega, GA,
USA) according to the manufacturer’s instructions. The amount of
mitochondrial DNA was determined by quantiﬁcation of cytochrome c
oxidase subunit II (COX2). The nuclear-encoded β-globin gene was used as
internal controls. Primers used in this study can be found in the
Supplementary Table 4.
The mitochondria of myoblast and gastrocnemius was isolated using the
Cell/Tissue Mitochondria Isolation Kit (C3601/C3606, Beyotime, China).
After measuring the mitochondrial protein concentration, freshly isolated
mitochondria were subjected to FAO rate assay with the Colorimetric Fatty
Acid Oxidation Rate Assay Kit (HL50679, Haling, Shanghai, China),
according to the manufacturer’s protocol.

Central carbon metabolic proﬁling

ZFP36L2-AS knockdown gastrocnemius samples (n = 6) were used for
metabolites extraction, and then performed on HPIC-MS/MS analysis. The
high-performance ion exchange liquid chromatography (HPIC) separation
was carried out using an Thermo Scientiﬁc Dionex ICS-6000 HPIC System
(Thermo Fisher Scientiﬁc, IL, USA). An AB SCIEX 6500 QTRAP + triple
quadrupole mass spectrometer (AB Sciex, USA), equipped with an
electrospray ionization (ESI) interface, was applied for assay development.
Metabolic hierarchical clustering analysis (HCA) was performed using
Cluster3.0 software as previously described [24].

Hematoxylin and eosin (H&E) staining and
immunohistochemistry (IHC)
H&E staining was performed using the Hematoxylin and Eosin Staining Kit
(Beyotime, Shanghai, China) following the manufacturer’s protocol.
Immunohistochemistry was carried out using SP-POD Kit (SP0041, Solarbio,
China) with primary antibodies included anti-MYH1(F59, 1:100, DHSB) and
anti-MYH7 (S58, 1:300, DHSB).

Metabolite and enzyme activities assays
Content of adenosine triphosphate (ATP), triglyceride (TG), free fatty acid
(FFA), glycogen, and acetyl-CoA as well as enzyme activity of lactic
dehydrogenase (LDH), succinate dehydrogenase (SDH), acetyl-CoA carboxylase (ACC) and pyruvate carboxylase (PC) in skeletal muscle were
measured using commercially available kits (BC0305, BC0625, BC0595,
BC0345, BC0980, BC0685, BC0955, BC0410 and BC0730, Solarbio, China)
according to the manufacturer’s instructions.

RNA pull-down assay
Ribo™ RNAmax-T7 biotin-labeled transcription kit (RiboBio, Guangzhou,
China) was used to harvest biotinylated RNAs. RNA pull-down assays were
performed with Pierce Magnetic RNA-Protein Pull-Down Kit (Thermo Fisher
Scientiﬁc, IL, USA), according to the manufacturer’s instructions. The eluted
products were identiﬁed by mass spectrometry with a Q Exactive mass
spectrometer (Thermo ﬁsher) or western blot. Differentially expressed
genes (DEGs) were subjected to enrichment analysis of Gene Ontology
(GO) functions and Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathways.
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RNA immunoprecipitation (RIP) assay
RIP assays were performed using the Magna RIP™ RNA-Binding Protein
Immunoprecipitation Kit (Millipore, CA, USA) following the manufacturer’s
protocol. The antibodies used for RIP assays were anti-ACACA (PA5-17564,
1:50, Thermo Fisher Scientiﬁc) and anti-PC (GTX132002, 1:100, GeneTex).

Statistical analysis
In this study, all experiments were repeated at least three times, and results
were represented as mean ± SEM. Where applicable, the statistical
signiﬁcance of the data was tested using independent sample t-test or
ANOVA followed by Dunnett’s test. The types of tests and the P values,
when applicable, are indicated in the ﬁgure legends.

DATA AVAILABILITY
All data generated or analysed during this study are included in this published article
(and its supplementary information ﬁles). Additional data related to this paper may
be available from the corresponding author on reasonable request.
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